Description
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of
type 2 diabetes and obesity. It works by mimicking the action of the natural GLP-1 hormone,
helping to regulate blood sugar levels, reduce appetite, and promote weight loss. Semaglutide
slows gastric emptying, enhances insulin secretion, and lowers glucagon levels. It is available in
injectable and oral forms and has shown significant effectiveness in improving glycemic control
and achieving substantial weight reduction in clinical trials.
Reviews
There are no reviews yet.